UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000003482
Receipt number R000004210
Scientific Title A Phase I /II Study of Tri-weekly XELIRI with Bevacizumab for patient with Metastatic Colorectal Cancer as second-line chemotherapy.
Date of disclosure of the study information 2010/04/13
Last modified on 2014/02/05 17:43:22

No. Disposal Last modified on Item of update
1 Insert 2010/04/13 11:13:12
2 Update 2014/02/05 17:43:22 Recruitment status
Publication of results